GEN Exclusives

More »

GEN News Highlights

More »
Jul 2, 2009

Novasep Purchases Henogen for Upstream Processing Capabilities

  • Novasep is acquiring Henogen thus adding a range of upstream processing capabilities and services to its downstream processing (DSP) offerings. Novasep reports that with this acquisition it will be able to offer a complete manufacturing solution for antibody-drug conjugates, covering early development to future commercial production.

    Henogen has more than 100 employees and operates two biomanufacturing facilities south of Brussels. It will become a part of Novasep Process, the biomolecules division. Henogen brings experience with an extensive array of expression tools including E. coli, yeast, L. lactis, insect and mammalian cells, as well as viral vectors.

    The two companies have previously cooperated on biomanufacturing projects. Combined services to be offered with this takeover now include upstream and downstream processing, contract biomanufacturing services, as well as chromatography and membrane-filtration technologies.

     



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?